Cyclophosphamide, Methotrexate and 5-Fluorouracil Combination Chemotherapy Versus Chloroethyl-Cyclohexy-Nitrosourea in the Treatment of Metastatic Prostatic Cancer
Author:
Affiliation:
1. From the Urologic Service, Memorial Sloan-Kettering Cancer Center, New York, New York
2. University of California, Irvine, California
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference17 articles.
1. Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma;Yagoda;Cancer,1973
2. Comparison of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in patients with advanced carcinoma of the prostate;Scott;Cancer Chemother. Rep.,1975
3. Comparison of adriamycin (NSC-123127) and 5-fluorouracil (NSC-19893) in advanced prostatic cancer;DeWys;Cancer Chemother. Rep.,1975
4. Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate;Schmidt;J. Urol.,1979
5. Treatment of advanced carcinoma of the prostate (stage D) with infusion of cis-diamminedichloroplatinum (II NSC 119875): a pilot study;Merrin;J. Urol.,1978
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer;Cancer Prevention Research;2009-12
2. Chemotherapy for hormone-refractory prostate cancer;Cochrane Database of Systematic Reviews;2006-10-18
3. Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group;BMC Cancer;2006-05-02
4. New standards in the chemotherapy of metastatic hormone-refractory prostate cancer;Expert Review of Anticancer Therapy;2005-01
5. Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding;British Journal of Cancer;2004-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3